Document Classification

Section Type: RESULTS

Text: The rate of freedom from treatment failure at five years was 69 percent in the COPP-ABVD group, 76 percent in the BEACOPP group, and 87 percent in the increased-dose BEACOPP group (P = 0. 04 for the comparison of the COPP-ABVD group with the BEACOPP group and P < 0. 001 for the comparison of the increased-dose BEACOPP group with the COPP-ABVD group and with the BEACOPP group), and the five-year rates of overall survival were 83 percent, 88 percent, and 91 percent, respectively (P = 0. 16 for the comparison of the COPP-ABVD group with the BEACOPP group, P = 0. 06 for the comparison of the BEACOPP group with the increased-dose BEACOPP group, and P = 0. 002 for the comparison of the COPP-ABVD group with the increased-dose BEACOPP group).